GoodRx Holdings (GDRX) Gross Margin (2019 - 2026)

GoodRx Holdings has disclosed Gross Margin across 8 years of filings, most recently posting 89.52% for Q2 2026.

• In Q2 2026, Gross Margin fell 390.0% year-over-year to 89.52%; the TTM figure through Jun 2026 stood at 90.83% (down 285.0% YoY), while the FY2025 annual figure was 92.77%, down 114.0% from the prior year.
• Gross Margin came in at 89.52% for Q2 2026 at GoodRx Holdings, roughly flat from 89.61% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 94.08% in Q2 2024 to a low of 89.52% in Q2 2026.
• Average Gross Margin over 5 years is 91.99%, with a median of 91.84% recorded in 2023.
• Year-over-year, Gross Margin soared 442 bps in 2024 and plunged 390 bps in 2026.
• Over 5 years, Gross Margin stood at 90.57% in 2022, then climbed by 2 bps to 92.29% in 2023, then increased by 2 bps to 93.86% in 2024, then dropped by 3 bps to 91.03% in 2025, then declined by 2 bps to 89.52% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 89.52% in Q2 2026, 89.61% in Q1 2026, and 91.03% in Q4 2025.